NFKB1 and Schnyder corneal dystrophy: Therefore, β-conglycinin from the SCD samples potentially contributed to anti-inflammation through the inhibition of the NF-κB signaling pathway and inhibition of inflammation-related enzymes as was shown in the correlations.